Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication Jun 6, 2023 08:30AM
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants Jul 20, 2022 08:30AM
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only Jan 14, 2022 12:15PM
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease Nov 23, 2021 07:00AM
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions May 12, 2021 08:00AM


Apr 22, 2021 08:00AM ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes
Apr 14, 2021 08:00AM ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
Sep 15, 2020 09:00AM ProtoKinetix AAGP® Restores Vision in Blind Test Subjects
Aug 27, 2020 09:00AM Ammendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials Have Been Approved by Health Canada
Aug 14, 2020 09:00AM ProtoKinetix AAGP® Moves to Whole Organ Transplantation Testing
Jul 13, 2020 08:30AM Amendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials by the University of Alberta Submitted to Health Canada
Jul 7, 2020 08:30AM ProtoKinetix AAGP® Dry Eye Program Advancing
Apr 6, 2020 08:30AM ProtoKinetix AAGP® Exhibits Efficacy and Safety in Model of Dry Eye Disease
Mar 24, 2020 08:30AM ProtoKinetix Ready to Ship AAGP® to the University of Alberta for the Continuation of Phase 1 Human Trials
Mar 19, 2020 09:00AM ProtoKinetix Files for Patent Protection for AAGP® to be Used in Dry Eye Disease
Feb 19, 2020 09:00AM ProtoKinetix Announces Progress in the use of AAGP® in Cardiovascular Medicine
Feb 11, 2020 08:00AM ProtoKinetix Files for Patent Protection for the Use of AAGP® in Transplant Medicine
Jan 24, 2020 08:30AM ProtoKinetix Takes Delivery of GMP AAGP® PKX-001 Dedicated for Phase 1 Trial
Jan 6, 2020 08:30AM ProtoKinetix AAGP® Dry Eye Therapy Testing Results
Dec 19, 2019 08:30AM ProtoKinetix AAGP® Retinal Cell Replacement Therapy Testing at UBC Completed
Nov 22, 2019 09:00AM ProtoKinetix AAGP® Dry Eye Therapy Program Launched
Nov 6, 2019 09:00AM ProtoKinetix AAGP® Operational Update
Aug 23, 2019 09:00AM Tests Show AAGP® Preserved and Enabled Retinal Cells to Mature Without Compromise after 5-Month Milestone
Jul 9, 2019 09:00AM ProtoKinetix Reaches Mid-Point of 3rd Stage of Retinal Cell Replacement Therapy Testing at UBC